Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 208143
Company: BRACCO
Company: BRACCO
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ENTERO VU 24% | BARIUM SULFATE | 24% (144GM/600ML) | SUSPENSION;ORAL | Prescription | None | Yes | Yes |
LIQUID E-Z-PAQUE | BARIUM SULFATE | 60% (213GM/BOT) | SUSPENSION;ORAL | Prescription | None | Yes | Yes |
READI-CAT 2 | BARIUM SULFATE | 2% (9GM/BOT) | SUSPENSION;ORAL | Prescription | None | Yes | Yes |
READI-CAT 2 SMOOTHIE | BARIUM SULFATE | 2% (9GM/BOT) | SUSPENSION;ORAL | Prescription | None | Yes | Yes |
TAGITOL V | BARIUM SULFATE | 40% (8GM/BOT) | SUSPENSION;ORAL | Prescription | None | Yes | Yes |
VARIBAR HONEY | BARIUM SULFATE | 40% (100GM/250ML) | SUSPENSION;ORAL | Prescription | None | Yes | Yes |
VARIBAR NECTAR | BARIUM SULFATE | 40% (96GM/240ML) | SUSPENSION;ORAL | Prescription | None | Yes | Yes |
VARIBAR THIN HONEY | BARIUM SULFATE | 40% (100GM/250ML) | SUSPENSION;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/15/2016 | ORIG-1 | Approval | Type 7 - Drug Already Marketed without Approved NDA | STANDARD |
Label (PDF)
Letter (PDF) Review |
Letter and Label for READI-CAT and READI-CAT 2 SMOOTHIE | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208143s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208143Orig1s000Approvedt.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208143_toc.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
03/10/2022 | SUPPL-13 | Manufacturing (CMC)-Packaging |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/208143Orig1s013ltr.pdf |
05/29/2020 | SUPPL-11 | Efficacy-New Indication |
Label (PDF)
Letter (PDF) |
Letter and Label for ENTERO VU 24% | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208143s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208143Orig1s011ltr.pdf |
03/26/2018 | SUPPL-7 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
Letter and Label for VARIBAR HONEY | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208143s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208143Orig1s007ltr.pdf |
01/23/2018 | SUPPL-6 | Efficacy-New Patient Population |
Label (PDF)
Letter (PDF) |
Letter and Label for VARIBAR THIN HONEY | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208143s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208143Orig1s006ltr.pdf |
08/04/2017 | SUPPL-5 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
Label for TAGITOL V | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208143s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208143Orig1s005ltr.pdf |
07/07/2017 | SUPPL-4 | Efficacy-New Dosing Regimen |
Label (PDF)
Letter (PDF) |
Label for VARIBAR NECTAR | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208143s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208143Orig1s004ltr.pdf |
02/08/2017 | SUPPL-3 | Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) |
Letter and Label for READI-CAT and READI-CAT 2 SMOOTHIE | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208143s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208143Orig1s003ltr.pdf |
03/01/2017 | SUPPL-2 | Efficacy-New Indication |
Label (PDF)
Letter (PDF) |
Letter and Label for LIQUID E-Z-PAQUE | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208143s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208143Orig1s002ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
05/29/2020 | SUPPL-11 | Efficacy-New Indication | Label (PDF) | Letter and Label for ENTERO VU 24% | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208143s011lbl.pdf |
03/26/2018 | SUPPL-7 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | Letter and Label for VARIBAR HONEY | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208143s007lbl.pdf |
01/23/2018 | SUPPL-6 | Efficacy-New Patient Population | Label (PDF) | Letter and Label for VARIBAR THIN HONEY | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208143s006lbl.pdf |
08/04/2017 | SUPPL-5 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | Label for TAGITOL V | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208143s005lbl.pdf |
07/07/2017 | SUPPL-4 | Efficacy-New Dosing Regimen | Label (PDF) | Label for VARIBAR NECTAR | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208143s004lbl.pdf |
03/01/2017 | SUPPL-2 | Efficacy-New Indication | Label (PDF) | Letter and Label for LIQUID E-Z-PAQUE | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208143s002lbl.pdf |
02/08/2017 | SUPPL-3 | Labeling-Container/Carton Labels | Label (PDF) | Letter and Label for READI-CAT and READI-CAT 2 SMOOTHIE | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208143s003lbl.pdf |
01/15/2016 | ORIG-1 | Approval | Label (PDF) | Letter and Label for READI-CAT and READI-CAT 2 SMOOTHIE | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208143s000lbl.pdf |